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There was a great sense of optimism from the very beginning. 
The tone was set by Richard Young (Whitehead Institute, MIT), 
who, in his keynote talk, outlined how the last decade of dis-
coveries and technological advances has taken the epigenetic 
field to a whole new level. He detailed how our basic biochemi-
cal exploration of histones and chromatin has laid the molecular 
groundwork for stem cell biology, scrutiny of diseases and drug 
discovery.
A remarkable lineup of speakers followed over the days to 
come making each session a must see event. I highlight below 
only some of the talks, which mainly focused on new and differ-
ent methodologies and the evolution of this rapidly expanding 
field, but other topics of note from the meeting include chroma-
tin assembly and remodeling, replication dynamics and pioneer-
ing work in DNA demethylation.
Reconstruction of Cellular Networks  
with Genome-wide Functional Annotation
In his talk, Brad Bernstein (Mass General Hospital and Harvard 
Medical School) detailed two highly complementary studies lead 
by Manolis Kellis and himself, employing genome-wide func-
tional annotation of the human genome to reconstruct cellular 
networks. Using ChIP-seq, nine different histone modifications 
were mapped globally across nine human cell types. Distinct 
combinations of modifications defined 15 enriched chromatin 
states, which in turn were used to functionally annotate chromo-
somal regions. Enhancers show significant cell type-specific sig-
natures whereas promoter states are more stable across cell types. 
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Keystone Symposia kicked off the start of 2012 with two joint 
meetings on epigenomics and Chromatin Dynamics and a star-
studded list of speakers. Held in Keystone, Co, January 17–22, 
and organized by Steven Jacobsen and Steven Henikoff and 
by Bradley Cairns and geneviève Almouzni, respectively, there 
was plenty happening in these sessions that it did not seem to 
matter that the ski-slope conditions were not ideal.
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Promoter and enhancer chromatin states could then be correlated 
with activities of nearby genes whereby functional gene clusters 
emerged specific to each cell type. In keeping with cell type-
specificity of both enhancer signatures and expression of gene 
clusters, strong enhancers are particularly enriched for transcrip-
tion factor (TF) binding motifs recognized by cell type-specific 
TFs. Strikingly, non-coding, disease-associated SNPs also show 
enrichment in these cell type-specific enhancer regions and can 
indeed be linked to diseases involving the particular cell type. By 
comparing across cell types, insights are gained into transcrip-
tional networks and candidate disease mechanisms that would 
otherwise have been difficult to elucidate. To further explore 
the functional significance of these chromatin states, ChIP-seq 
analyses of 34 known chromatin regulators (CRs) were suc-
cessfully performed and binding profiles mapped. Interestingly, 
significant modular co-localization of CRs was observed across 
cell types. Modules localize to distinct chromatin states, reflect 
specific histone modification profiles and even associate with 
coherent gene sets with related functions. Intriguingly, CRs with 
opposing functions often coexist in the same modules possibly 
enabling dynamic regulation and fine-tuning of the associated 
gene clusters.
Increased Epigenetic Plasticity in Tumor Tissues
Andrew Feinberg’s (Johns Hopkins University) talk was focused 
on the increased epigenetic plasticity associated with the transi-
tion from normal to tumor tissue. Comparing numerous normal 
tissues and corresponding solid tumor samples, Feinberg’s lab 
identified hyper-variable chromosomal regions named Variably 
Methylated Regions (VMRs). These are differentially methyl-
ated in cancers and often localize to cell cycle and developmen-
tal genes. Between individuals, VMR methylation patterns in 
tumors are much more heterogeneous than those in the par-
ent tissues, suggesting that stochastic methylation events drive 
tumor development. Importantly, however, a “productive” subset 
of stochastic outcomes appears to be selected for, as methylation 
patterns in cancer often resemble patterns of other normal tis-
sues. These observations could tie stochastic methylation events 
not only to tumor development but also to tissue differentia-
tion and evolutionary adaptation in general. Also, large blocks © 2012 Landes Bioscience.
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cell cycle genes and are differentially expressed in cancers. One 
example is the 1.5 kb PANDA lncRNA, transcribed from the 
CDKN1A promoter in parallel with the coding mRNA. Both 
transcripts are induced with different kinetics by p53 upon DNA 
damage and are involved in coordinating the cellular response. 
CDKN1A mRNA translates into the cell cycle inhibitor p21 and 
PANDA act as a decoy blocking the pro-apoptotic transcription 
factor NP-YA. Remarkably, a point mutation in p53—occur-
ring in certain cancers—dissociates induction of the two tran-
scripts allowing only the anti-apoptotic PANDA transcript to be 
formed. Extended analyses of the transcriptome using increas-
ingly sophisticated methods expose a novel network of chromatin 
regulation in which long distance interactions through non-cod-
ing transcripts can transfer chromatin state information from one 
locus to another without protein translation.
Meeting Wrap-up
In conclusion, the chromatin field has broadly benefited from 
recent advances in molecular imaging, sequencing technology 
and computational methods giving every reason to join keynote 
speaker Rick Young in his optimism. Long-range interactions 
involving enhancers, non-coding transcripts and large chro-
mosomal features are being characterized and linked to cellu-
lar function and overall nuclear architecture. Insights are being 
gained that greatly facilitate the continued exploration of com-
plex, multi-cellular processes such as fetal development, cellular 
adaptation and aging. At the same time, high-throughput meth-
ods allow comparisons of an increasing number of specimens and 
reveal patterns and concepts that hold big promises for chroma-
tin-based disease diagnostics and therapeutics.
Note
A version of this report appeared previously on line at the Epigenie 
website (www.epigenie.com).
of hypomethylated and rare, hypermethylated blocks were found 
throughout the tumor genomes. These largely overlap with previ-
ously described Partly Methylated Domains (PMDs) and Large 
Organized Chromatin K9 Modifications (LOCKs) contain-
ing the majority of known nuclear lamina associated domains 
(LADs) of the chromosomes.
In her talk, Shelley Berger (University of Pennsylvania) 
described a correlation between cellular aging and loss of chro-
matin organization. Senescent human fibroblasts show large 
chromosomal regions with decreased H3K27 methylation or 
increased H3K4 trimethylation associated with reduced or 
increased nuclear lamina binding, respectively. No DNA meth-
ylation data was presented. Learning more about sub-nuclear 
organization of chromatin at a larger scale could ultimately help 
us understand highly complex multi-factorial processes, such as 
cellular transformation and aging.
Relationships between Histone Modifications  
and Chromatin States
Whereas correlations between many histone modifications and 
various chromatin states are well established, the function of these 
marks is an area of continued debate. Genome-wide studies in 
yeast by Steve Buratowski’s (Harvard Medical School) and Ollie 
Rando’s (University of Massachusetts) laboratories were designed 
to address the roles of H3K4 methylation as well as other modifi-
cations. Histone H3K4 di and trimethylation is widely observed 
over coding regions and highly correlated with gene activity. In 
both studies, however, loss of either Set1-catalyzed deposition of 
H3K4 methyl marks or loss of H3K4 methyl “readers” such as 
Set3 affected only few genes. Of the genes affected, more were 
de-repressed than repressed and a majority overlapped with non-
coding transcripts. Loss of H3K4 methylation in coding regions 
resulted in cryptic initiation from internal promoters. Likewise, 
coding genes immediately downstream of non-coding genes were 
de-repressed. A common mechanism proposed by Rando and 
Buratowski was H3K4 methylation-directed histone deacety-
lation. Clearly, care has to be taken when interpreting correla-
tions. Although the presence of a distinct nucleosome signature 
can have predictive value, the function of a given histone mark 
is highly context dependent. The better genomes become anno-
tated with cryptic transcriptional elements and non-coding tran-
scripts, the better the functional impact of epigenetic marks and 
histone signatures is understood.
Non-coding RNAs and Transcription
Non-coding RNAs were also at the center of Howard Chang’s 
(Stanford Medical School) talk. Long non-coding (lnc) RNAs 
have recently been shown to play a key role in transcriptional 
regulation. These are capped and polyadenylated and can be 
transcribed from promoters or enhancers in either sense or anti-
sense direction relative to the nearby coding gene. LncRNAs may 
function in either cis or trans as guides for chromatin modifiers, 
as scaffolds, transcriptional enhancers or as decoys with signifi-
cant impact on cell fate. A large number of lncRNAs localize to 